多发性骨髓瘤 CAR-NK 细胞治疗的最新进展:细胞来源与靶抗原的综合综述 State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. PubMed 2025/11/20 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞
CAR-T 与 CAR NK 细胞的在靶脱瘤效应差异提示细胞治疗的疗效与安全性不同 Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies. PubMed 2025/09/05 发表OncoimmunologyQ1 · IF 6.2(JCR 2025) 靶点:CD38靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞多发性骨髓瘤